IBA Molecular and Mallinckrodt Nuclear Medicine LLC have come together to form one singular global organization: Curium.
The new name is derived from two inspirational sources – the pioneering spirit and radiation research of Marie and Pierre Curie, and Curium’s our own focus on nuclear medicine.
They will continue to channel resources and investment into our industry to support its growing role in global healthcare. It is all part of Curium & Mallinckrodt’s aim to become a catalyst of Nuclear Medicine industry growth.
The visual identity for Curium was designed to convey continuity and advancement along the patient care continuum. Their brand tagline, Life Forward, encapsulates their commitment to customers and the industry we serve.
Together, these two branding elements demonstrate our dedication to enhancing the quality of health outcomes.Share